ASH 2021 Post-Conference Perspectives: Updates in Multiple Myeloma - Episode 6

2-Year Followup Data From the GRIFFIN Trial in Transplant-Ineligible NDMM

Updated results from the GRIFFIN trial in newly diagnosed multiple myeloma, including consideration for frontline 4-drug regimens and depth of response.